WOODROW ADAM (VP & Chief Commercial Officer) sold 2.1% of their position (10.97K shares) of PARATEK PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $56.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/18/2021ACC: 0000904454-21-000622
Officer· VP & Chief Commercial Officer
Since Oct 2018
+26.52K
Net shares
Net buyer
$56.2K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
37.50K acquired · 10.97K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+37.50K
Price / share
—
Trade value
—
% of position
7.9%
8/16/2021
474.80K→512.30K
Common Stock
Direct
Shares
−10.97K
Price / share
$5.12
Trade value
$56.19K
% of position
2.1%
8/17/2021
512.30K→501.32K
Total
Net shares
+26.52K
Net value
-$56.19K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/16/2021 | A · Award | +37.50K | — | — | 7.9% | 474.80K | 512.30K |
| Common Stock Direct | 8/17/2021 | S · Sale | −10.97K | $5.12 | $56.19K | 2.1% | 512.30K | 501.32K |
| Total | +26.52K | -$56.19K | ||||||
Derivative Transactions0
No derivative transactions reported